The spectrum of vascular involvement in giant-cell arteritis: Clinical consequences of detrimental vascular remodelling at different sites

APMIS

Volumn 117, Issue SUPPL. 127, 2009, Pages 10-20

  Cid, Maria C ^a   Prieto GonzÁlez, Sergio ^a   Arguis, Pedro ^a,b   EspÍgol FrigolÉ, Georgina ^a   Butjosa, Montserrat ^a   HernÁndez RodrÍguez, José ^a   Segarra, Marta ^a   Lozano, Ester ^a   GarcÍa MartÍnez, Ana ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Angiography; Extracranial involvement; Giant cell arteritis; Vascular remodelling; Vasculitis

Indexed keywords

EPIDERMAL GROWTH FACTOR; FLUORODEOXYGLUCOSE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MACROPHAGE ELASTASE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; ECHOGRAPHY; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; ANIMAL; AORTA; BLOOD VESSEL; CAROTID ARTERY; ILIAC ARTERY; LIMB; PATHOLOGY; RENAL ARTERY; REVIEW; SUBCLAVIAN ARTERY; VASCULARIZATION; VERTEBRAL ARTERY;

ANIMALS; AORTA; BLOOD VESSELS; CAROTID ARTERIES; EXTREMITIES; GIANT CELL ARTERITIS; HUMANS; ILIAC ARTERY; RENAL ARTERY; SUBCLAVIAN ARTERY; VERTEBRAL ARTERY;

EID: 66949133924     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02471.x     Document Type: Conference Paper

References (85)

1. Maksimowicz-McKinnon K, Hoffman GS. Large vessel vasculitis. Clin Exp Rheumatol 2007 25 (Suppl 44) : S58 9.
2. Cid MC, Font C, Coll-Vinent B, Grau JM. Large vessel vasculitides. Curr Opin Rheumatol 1998 10 : 18 28. (Pubitemid 28058511)
3. Hunder GG, Ward E, Burbank MK. Giant-cell arteritis producing an aortic arch syndrome. Ann Intern Med 1967 66 : 578 82.
4. Perruquet JL, Davis DE, Harrington TM. Aortic arch arteritis in the elderly. An important manifestation of giant-cell arteritis. Arch Intern Med 1986 146 : 289 91.
5. Monterio MLR, Coppeto JR, Greco P. Giant-cell arteritis of the posterior cerebral circulation presenting with ataxia and ophthalmoplegia. Arch Ophthalmol 1984 102 : 407 9.
6. Howard GF III., Ho SU, Kim KS, Wallach J. Bilateral carotid artery occlusion resulting from giant-cell arteritis. Ann Neurol 1984 15 : 204 7.
7. Small P. Giant-cell arteritis presenting as a bilateral stroke. Arthritis Rheum 1984 27 : 819 21.
8. Collado A, Santamaría J, Cid MC, Ribalta T, Tolosa Sarro E. Giant cell arteritis presenting with ipsilateral hemiplegia and lateral medullary syndrome. Eur Neurol 1989 29 : 266 8.
9. Walz-Leblanch BE, Michael Ameli F, Keystone EC. Giant-cell arteritis presenting as limb cludication. Report and review of the literature. J Rheumatol 1991 18 : 470 2.
10. Evans JM, O'FAllon M, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant-cell (temporal) arteritis. A population-based study. Ann Intern Med 1995 122 : 502 7.
11. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Incidence and predictors of large artery complication/aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant-cell arteritis. A population-based study over 50 years. Arthritis Rheum 2003 48 : 3522 31.
12. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009 21 : 19 28.
13. 18]F FDG PETand MRI. Eur J Nucl Med Mol Imaging 2003 30 : 730 6.
14. Narváez J, Narváez JA, Nolla JM, Sirvent E, Reina D, Valverde J. Giant-cell arteritis and polymyalgia reumática: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology 2005 44 : 479 83.
15. Schmidt WA, Natusch A, Moller DE, Vorpahl K, Gromnica-Ihle E. Involvement of peripheral arteries in giant-cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol 2002 20 : 309 18.
16. Canyigit M, Peynircioglu B, Hazirolan T, Gulbiz Dagoglu M, Erhan C, Haliloglu M, et al. Imaging characteristics of Tajkayasu arteritis. Cardiovasc Intervent Radiol 2007 30 : 711 8.
17. 18F-FDG PET: introducing a ROC-Analysis-based cut off ratio. J Nucl Med 2008 49 : 1107 13.
18. Tso E, Flamm SD, White RD, Schwartzman PR, Mascha E, Hoffman GS. Takayasu arteritis. Utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002 46 : 1634 42.
19. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant-cell arteritis. Rheumatology 2008 47 : 96 101. (Pubitemid 350286272)
20. 18F-fluorodeoxyglucose positron emission tomography in giant-cell arteritis: a preospective study of 35 patients. Arthritis Rheum 2006 55 : 131 7.
21. García-Martínez A, Hernández-Rodríguez J, Arguis P, Paredes P, Lozano E, Nicolau C, et al. Development of aortic aneurysm/dilatation during the follow-up of patients with giant-cell arteritis. A cross-sectional screening in 54 prospectively treated patients. Arthritis Rheum 2008 59 : 422 30.
22. Hunder GG. The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970. Mayo Clin Proc 2006 81 : 1071 83.
23. Save- Söderbergh J, Malmvall BE, Andersson R, Bengtsson BA. Giant-cell arteritis as a cause of death. Report of nine cases. JAMA 1986 255 : 493 6.
24. Ostberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand 1972 533 (Suppl) : 133 59.
25. Walter MA, Melzer RA, Schindler C, Müller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005 32 : 674 81.
26. Evans JM, Bowles CA, Bjornsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994 37 : 1539 47.
27. Nuenninghoff DM, Hunder GG, Christianson TJH, McClelland RL, Matteson EL. Mostality of large-artery complication (aortic aneurysm, aortic dissection, and/or large artery stenosis) in patients with giant-cell arteritis. A population-based study over 50 years. Arthritis Rheum 2003 48 : 3532 27.
28. González-Gay MA, García-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain. Medicine (Baltimore) 2004 83 : 335 41.
29. Bongarz T, Matteson EL. Large-vessel involvement in giant-cell arteritis. Curr Opin Rheumatol 2006 18 : 10 7.
30. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995 24 : 422 31.
31. Blockmans D, Stroobans S, Maes A, Mortelmans L. Positron emission tomography in giant-cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000 108 : 246 9.
32. Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant-cell arteritis. Ann Rheum Dis 2006 67 : 1030 3.
33. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, López-Soto A, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998 41 : 26 32. (Pubitemid 28041919)
34. Hernández-Rodríguez J, García-Martínez A, Casademont J, Filella X, Esteban MJ, López-Soto A, et al. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum 2002 47 : 29 35. (Pubitemid 34137341)
35. González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998 41 : 1497 504.
36. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005 84 : 269 76.
37. Klein RG, Hunder GG, Stantson AW. Large artery involvement in giant-cell (temporal) arteritis. Ann Intern Med 1975 83 : 806 12.
38. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994 120 : 919 2.
39. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, et al. Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum 2005 53 : 100 7.
40. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007 56 : 1000 9.
41. Thompson JR, Simmons CR, Smith LL. Polymyalgia rheumatica with bilateral subclavian artery occlusive disease. Radiology 1971 101 : 595 6.
42. Kalimanovska-Ostric DV, Simic-Ogrizovic SP, Bonaci-Nikolic BM, Bozic VD, Ostric VZ, Davidovic LB. Heart and renal failure in renovascular hypertension caused by giant cell arteritis - case report. Clin Nephrol 2007 67 : 58 60. (Pubitemid 46321746)
43. Lambert M, Weber A, Boland B, De Plaen JF, Donckier J. Large vessel vasculitis without temporal artery involvement: isolated form of giant-cell arteritis? Clin Rheumatol 1996 15 : 174 80.
44. Both M, Aries PM, Müller-Hülsbeck S, Jahnke T, Schäfer PJ, Gross WL, et al. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis 2006 65 : 1124 30.
45. Amann-Vesti BR, Koppensteiner R, Rainoni L, Pfamatter T, Schneider E. Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis. J Endovasc Ther 2003 10 : 371 5.
46. Dellaripa PF, Eisenhauer AC. Bilateral percutaneous balloon angioplasty of the axillary arteries in a patient with giant cell arteritis and upper extremity ischemic symptoms not responsive to corticosteroids. J Rheumatol 1998 25 : 1429 33.
47. Lambert M, Weber A, Boland B, De Plaen JF, Donckier J. Large vessel vasculitis without temporal artery involvement: isolated form of giant cell arteritis? Clin Rheumatol 1996 15 : 174 80.
48. Brack A, Martínez-Taboada VM, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant-cell arteritis. Arthritis Rheum 1999 42 : 311 7.
49. Tatò F, Hoffman U. Clinical presentation and vascular imaging in giant-cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 2006 44 : 176 82.
50. Tatò F, Hoffman U. Giant-cell arteritis: a systemic vascular disease. Vasc Med 2008 13 : 127 40.
51. McCain GA, Thompson JM. Isolated giant-cell arteritis. J Rheumatol 1978 5 : 674 6.
52. Cid MC, Cervera R, Font J, Campo E, López-Soto A. Recurrent arterial thrombosis in a patient with giant-cell arteritis and raised anticardiolipin antibody levels. Br J Rheumatol 1988 27 : 164 6.
53. Scola CJ, Li C, Upchurch KS. Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore) 2008 87 : 45 51.
54. Sujobert P, Fardet L, Marie I, Duhaut P, Cohen P, Grange C, et al. Mesenteric ischemia in giant cell arteritis: 6 cases and a systematic review. J Rheumatol 2007 34 : 1727 32.
55. Wilkinson IM, Russell RW. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 1972 27 : 378 91.
56. Cid MC, Hernández-Rodríguez J, García- Martínez J, Espígol-Frigolé J, Prieto-González S, Butjosa M, et al. The temporal artery biopsy. A diagnosis and research tool. Int J Clin Rheumatol, in press.
57. Schmidt WA, Kraft HE, Vorpahl K, Völker L, Gromnica-Ihle EJ, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997 337 : 1336 42.
58. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Diagnostic performance of ultrasonography for giant-cell arteritis: a meta-analysis. Ann Intern Med 2005 142 : 359 6.
59. Bley TA, Reinhard M, Hauenstein C, Warnatz MK, Hetzel A, Uhl M, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant-cell (temporal) arteritis). Arthritis Rheum 2008 58 : 2574 8.
60. Bley TA, Weiben O, Uhl P, Vaith P, Schmidt K, Warnatz K, et al. Assessment of the cranial involvement pattern of giant-cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum 2005 52 : 2470 7.
61. Solans-Laqué R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M. Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. Medicine (Baltimore) 2008 87 : 335 44.
62. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant-cell (temporal) arteritis. Neurology 1988 38 : 352 9.
63. Reich KA, Giansiracusa DF, Strongwater SL. Neurologic manifestations of giant-cell arteritis. Am J Med 1990 89 : 67 72.
64. Gonzalez-Gay MA, Piñeiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004 83 : 342 7.
65. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, European Vasculitis Study Group, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009 68 : 318 23.
66. Foroozan R, Deramo VA, Buono LM, Jayamanne DE, Sergott RC, Danesh Meyer H, et al. Recovery of visual function in patients with biopsy-proven giant-cell arteritis. Opththalmology 2003 110 : 539 42.
67. Esteban MJ, Font C, Hernández-Rodríguez J, Valls J, Sanmartí R, García-Martínez A, et al. Small vessel vasculitis surrounding a spared temporal artery: clinical and pathologic findings in a series of 28 patients. Arthritis Rheum 2001 44 : 1387 95.
68. Crompton MR. The visual changes in temporal (giant-cell) arteritis: report of a case with autopsy findings. Brain 1959 82 : 377 90.
69. Kattah JC, Mejico L, Chrousos GA, Zimmerman LE, Manz HJ. Pathologic findings in a steroid-responsive optic nerve infarct in giant-cell arteritis. Neurology 1999 53 : 177 80.
70. Geiger J, Ness T, Uhl M, Lagrèze WA, Vaith P, Langer M, et al. Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology (Oxford) 2009 48 : 537 41.
71. Ho AC, Sergott RC, Regillo CD, Savino PJ, Lieb WE, Flaharty PM, et al. Color Doppler hemodynamics of giant cell arteritis. Arch Ophthalmol 1994 112 : 938 45.
72. Garcia-Porrua C, Pego-Reigosa R, Armesto V, Gonzalez-Gay MA. Neovascularization around the optic nerve in giant cell arteritis. Arthritis Rheum 2003 15 : 737 8.
73. Cid MC, Hernández-Rodríguez J, Esteban MJ, Cebrián M, Gho YS, Font C, et al. Tissue and serum angiogenic activity is associated with low prevalence of ischemic events in patients with giant-cell arteritis. Circulation 2002 106 : 1664 71.
74. Hayreh SS. Ischaemic optic neuropathy. Indian J Ophthalmol 2000 48 : 171 94.
75. Lozano E, Segarra M, Corbera-Bellalta M, García-Martínez A, Espígol-Frigolé G, Plà-Campo A, et al. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis. Association between elevated endothelin plasma levels and the development of ischemic events. Ann Rheum Dis 2009 Mar 15 [Epub ahead of print].
76. Font C, Cid MC, Coll-Vinent B, López-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997 36 : 251 4.
77. Nesher G, Berkun Y, Mates M, Baras M, Nesher R, Rubinow A, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004 83 : 114 22.
78. Cid MC, García-Martínez A, Lozano E, Espígol- Frigolé G, Hernández-Rodríguez J. Management of giant-cell arteritis. Five clinical conundrums. Clin Rheum Dis North Am 2007 33 : 819 34.
79. Esteban MJ, Font C, Hernández-Rodríguez J, Valls J, Sanmartí R, García-Martínez A, et al. Small vessel vasculitis surrounding a spared temporal artery: clinical and pathologic findings in a series of 28 patients. Arthritis Rheum 2001 44 : 1387 95.
80. Segarra M, García-Martínez A, Sánchez M, Hernández-Rodríguez J, Lozano E, Grau JM, et al. Gelatinase expression and proteolytic activity in giant-cell arteritis. Ann Rheum Dis 2007 66 : 1429 35.
81. Kaiser M, Weyand CM, Björnsson J, Goronzy JJ. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant-cell arteritis. Arthritis Rheum 1998 41 : 623 3.
82. Lozano E, Segarra M, García-Martínez A, Hernández-Rodríguez J, Cid MC. Imatinib mesylate inhibits in vitro and ex vivo biologic responses related to vascular occlusion in giant-cell arteritis. Ann Rheum Dis 2008 67 : 1581 8.
83. Lie JT, Brown AL, Carter ET. Spectrum of aging changes in temporal arteries. Its significance, in interpretation of biopsy of temporal artery. Arch Pathol 1970 90 : 278 85.
84. Visvanathan S, Rahman MU, Hoffman GS, Xu S, García-Martínez A, Segarra M, et al. Tissue and serum levels of selected markers of inflammation and relapse in giant cell arteritis: results from the infliximab phase 2 study. Arthritis Rheum 2008 58 : S613.
85. Lozano E, Segarra M, García-Martínez A, Espígol-Frigolé G, Hernández-Rodríguez J, Cid MC. Therapeutic targets in giant-cell arteritis. Clin Exp Rheumatol 2008 26 : S141 59.